🎁 💸 Warren Buffett's Top Picks Are Up +49.1%. Copy Them to Your Watchlist – For FreeCopy Portfolio

Tyson Foods' Says Reintroducing Antibiotics Yields Healthier Chickens

Published 16/05/2024, 16:21
© Reuters.  Tyson Foods' Says Reintroducing Antibiotics Yields Healthier Chickens
TSN
-

Benzinga - by Shivani Kumaresan, Benzinga Staff Writer.

Tyson Foods Inc. (NYSE:TSN) has reported positive outcomes from its decision to reintroduce some antibiotics into its poultry operations.

The company observed healthier birds with better weight gain and reduced mortality rates, according to CEO Donnie D. King.

The largest meat supplier in the U.S. had previously eliminated all antibiotics but reversed this decision last year, maintaining a commitment not to use antibiotics critical to human medicine, reported Bloomberg.

The move was tracked by chicken buyers like the restaurant operator Chick-Fil-A Inc.

This adjustment was part of Tyson's broader strategy to improve operational efficiency amid rising costs and a surplus of chicken supply.

King, speaking at the BMO Global Farm to Market conference in New York, highlighted that these efforts have resulted in a significantly stronger chicken business over the past year.

The company reported that in the second quarter of FY24, adjusted EBITDA increased by 25.5% to $1.5 billion. Adjusted EPS of $0.62 beat the consensus estimate of $0.39.

The demand for Tyson's chicken products has surged while the industry grapples with limited supply due to poor egg fertility and high mortality rates.

King noted that the company's measures, including plant closures and reintroducing certain antibiotics, have played a crucial role in this turnaround.

Additionally, Tyson has benefited from a decline in U.S. meat inventories and a reduction in feed costs.

However, King emphasized that the most significant improvements stemmed from internal efficiency measures, particularly the closure of six processing plants last year.

Despite these gains, the broader poultry industry continues to face challenges. Tyson's strategic moves, including its antibiotic policy shift, highlight the company's efforts to navigate these difficulties and maintain its market position.

Tyson's stock has gained more than 23% in the last 12 months. Investors can gain exposure to the stock via VanEck Agribusiness ETF (NYSE:MOO) and Invesco S&P 500 Equal Weight Consumer Staples ETF (NYSE:RSPS).

Price Action: TSN shares were trading lower by 0.05% at $60.68 at the last check on Thursday.

Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Photo via Shutterstock

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.